ENO2 and lung carcinoma: Presently recommended biomarkers for lung cancer include carcinoembryonic antigen (CEA), progastrin‐releasing peptide (ProGRP), cytokeratin 19 fragment (Cyfra21‐1), neuron‐specific enolase (NSE), and squamous cell carcinoma antigen (SCC).